EQUITY RESEARCH MEMO
fluidIQ
Generated 5/9/2026
Executive Summary
Conviction (model self-assessment)45/100
fluidIQ is a US-based public benefit corporation founded in 2019 that develops low-cost, electricity-free fluidic devices for emergency medical care, starting with a mechanical ventilator. The company's technology addresses critical gaps in resource-scarce environments, aiming to revolutionize fluid management and monitoring. With a focus on simplicity and effectiveness, fluidIQ's platform has the potential to improve outcomes in acute care settings globally. The company is privately held, with no disclosed funding or valuation, and operates in the digital health and diagnostics sectors.
Upcoming Catalysts (preview)
- Q4 2026FDA 510(k) clearance for the mechanical ventilator60% success
- Q2 2027Strategic partnership with a global health organization for field trials50% success
- Q3 2027Series A funding round to support product development and scaling70% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)